Sintilimab Combined With Stereotactic Body Radiotherapy as Neoadjuvant Therapy for Resectable Hepatocellular
Clinical trial NCT07352007 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07352007
- Sponsor
- Lei ZHAO
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-28
- Primary completion
- 2028-01-20
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.